» Articles » PMID: 18477249

Identification of Candidate Genes Involved in the Radiosensitivity of Esophageal Cancer Cells by Microarray Analysis

Overview
Journal Dis Esophagus
Specialty Gastroenterology
Date 2008 May 15
PMID 18477249
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy plays a key role in the control of tumor growth in esophageal cancer patients. To identify the patients who will benefit most from radiation therapy, it is important to know the genes that are involved in the radiosensitivity of esophageal cancer cells. Hence, we examined the global gene expression in radiosensitive and radioresistant esophageal squamous cell carcinoma cell lines. Radiosensitivities of 13 esophageal cancer cell lines were measured. RNA was extracted from each esophageal cancer cell line and a normal esophageal epithelial cell line, and the global gene expression profiles were analyzed using a 34 594-spot oligonucleotide microarray. In the clonogenic assay, one cell line (TE-11) was identified to be highly sensitive to radiation, while the other cell lines were found to be relatively radioresistant. We identified 71 candidate genes that were differentially expressed in TE-11 by microarray analysis. The up-regulated genes included CABPR, FABP5, DSC2, GPX2, NME, CBR3, DOCK8, and ABCC5, while the down-regulated genes included RPA1, LDOC1, NDN, and SKP1A. Our investigation provided comprehensive information on genes related to radiosensitivity of esophageal cancer cells; this information can serve as a basis for further functional studies.

Citing Articles

Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patients.

Saizonou I, Lascombe I, Monnien F, Bedgedjian I, Kleinclauss F, Algros M Sci Rep. 2024; 14(1):15390.

PMID: 38965292 PMC: 11224272. DOI: 10.1038/s41598-024-65972-8.


Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment.

Wu J, Guo J, Fang Q, Liu Y, Li C, Xie W Front Endocrinol (Lausanne). 2023; 14:1131693.

PMID: 37522128 PMC: 10376796. DOI: 10.3389/fendo.2023.1131693.


Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma.

Xie F, Zhang D, Qian X, Wei H, Zhou L, Ding C Ann Transl Med. 2022; 10(2):92.

PMID: 35282117 PMC: 8848450. DOI: 10.21037/atm-21-7032.


Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.

Liu Y, Zheng C, Huang Y, He M, Xu W, Li B MedComm (2020). 2021; 2(3):315-340.

PMID: 34766149 PMC: 8554658. DOI: 10.1002/mco2.55.


Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.

Wu P, Gao W, Su M, Nice E, Zhang W, Lin J Front Cell Dev Biol. 2021; 9:641469.

PMID: 33732706 PMC: 7957022. DOI: 10.3389/fcell.2021.641469.